COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
Jan. 12, 2026 |
Aug. 12, 2025 |
Aug. 01, 2024 |
Jun. 30, 2026 |
Nov. 04, 2025 |
Jun. 30, 2025 |
|---|---|---|---|---|---|---|
| Product Liability Contingency [Line Items] | ||||||
| Company recognized right of use asset | $ 1,751,040 | $ 69,520 | ||||
| Operating lease liability | $ 1,785,294 | 1,819,160 | ||||
| Lease modification | $ 129,755 | |||||
| Commitment payable | 1,357,742 | |||||
| Location, Statement of Financial Position, Balance [Axis]: us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent | ||||||
| Product Liability Contingency [Line Items] | ||||||
| Commitment payable | $ 739,266 | |||||
| CenExel HRI [Member] | ||||||
| Product Liability Contingency [Line Items] | ||||||
| Payment for milestone | $ 381,204 | |||||
| Cen Exel Clinical Research Inc [Member] | ||||||
| Product Liability Contingency [Line Items] | ||||||
| Payment for milestone | $ 976,538 | |||||
| Cambridge England [Member] | ||||||
| Product Liability Contingency [Line Items] | ||||||
| Lease expiration date | Aug. 31, 2025 | |||||
| Company recognized right of use asset | $ 1,785,294 |